USD 0.0
(0.0%)
Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | -1.71 Million | -429.26 Thousand | -1.09 Million | -918.18 Thousand | -739.59 Thousand |
Net Income | - | -879.2 Thousand | -84.97 Thousand | -1.19 Million | -5.84 Million | -2.98 Million |
Depreciation & Amortization | - | 12.11 Thousand | 46.9 Thousand | 14.99 Thousand | 81.76 Thousand | 96.4 Thousand |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | 3355.64 | 2092.87 |
Change in working capital | - | -930.15 Thousand | -415.48 Thousand | 100.85 Thousand | -113.95 Thousand | 40.84 Thousand |
Other non-cash items | - | 1.03 Million | 118.1 Thousand | -1206.00 | 4.96 Million | 2.11 Million |
Investing Cash Flow | - | -3.8 Million | - | 542.95 Thousand | - | - |
Investments in PPE | - | -8 Million | - | - | - | - |
Acquisitions | - | -3 Million | - | 13.74 Thousand | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | 7.2 Million | - | 529.2 Thousand | - | - |
Financing Cash Flow | - | 5.52 Million | 427.02 Thousand | 532.78 Thousand | 629.79 Thousand | 1.09 Million |
Debt repayment | - | -357.83 Thousand | -322.00 | -580.67 Thousand | -285.58 Thousand | -266.46 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | 5.37 Million | 413.78 Thousand | - | 664.91 Thousand | 1.18 Million |
Other Financing Activities | - | 511.69 Thousand | 12.91 Thousand | -47.88 Thousand | 250.46 Thousand | 168.89 Thousand |
Accounts receivables | - | -3.71 Million | - | 22.01 Thousand | -55.75 Thousand | -10.37 Thousand |
Accounts payables | - | 2.78 Million | - | - | -35.54 Thousand | -8310.00 |
Inventory | - | - | - | -99.00 | - | 540.00 |
Other working capital | - | - | -415.48 Thousand | 78.93 Thousand | -22.66 Thousand | 117.97 Thousand |
Cash at beginning of period | 15.85 Thousand | 1517.00 | 3749.00 | 18.82 Thousand | 352.49 Thousand | 2492.00 |
Cash at end of period | 15.85 Thousand | 15.85 Thousand | 1517.00 | 3749.00 | 18.82 Thousand | 352.49 Thousand |
Capital Expenditure | - | -8 Million | - | - | - | - |
Effect of forex changes on cash | - | -22.00 | - | - | -45.27 Thousand | -439.00 |
Net cash flow / Change in cash | - | 14.33 Thousand | -2232.00 | -15.07 Thousand | -333.67 Thousand | 350 Thousand |
Free Cash Flow | - | -9.71 Million | -429.26 Thousand | -1.09 Million | -918.18 Thousand | -739.59 Thousand |
Breakdown | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY | 2022 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | - | - | - | - | - | - |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | - | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | - | - | 15.85 Thousand | 15.85 Thousand |
Cash at end of period | - | - | - | - | 15.85 Thousand | 15.85 Thousand |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | - | - | - | - |
Free Cash Flow | - | - | - | - | - | - |
OXY-WT
ACNNF
MANKIND
KEC
ZONE
5289